Potent Anti-Myeloma Activity of the TOPK inhibitor OTS514 in Pre-Clinical Models. Potent Anti-Myeloma Activity of the TOPK inhibitor OTS514 in Pre-Clinical Models
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA526885
下载链接
链接失效反馈官方服务：
资源简介：
Evaluation of gene expression upon treatment with OTS514 in combination with existing thereapeutics in H929 cells Overall design: H929 cells treated for 24h with DMSO control or OTS514 (15 nM) and/or carfilzomib(CFZ, 5nM) and/or lenalidomide (LEN, 15µM)
创建时间：
2019-03-13
